Literature DB >> 9612303

Interferon-gamma stimulates human Clara cell secretory protein production by human airway epithelial cells.

X L Yao1, T Ikezono, M Cowan, C Logun, C W Angus, J H Shelhamer.   

Abstract

Clara cell secretory protein (CCSP) is an inhibitor of secretory phospholipase A2. It is produced by airway epithelial cells and is present in airway secretions. Because interferon (IFN)-gamma can induce gene expression in airway epithelial cells and may modulate the inflammatory response in the airway, it was of interest to study the effect of this cytokine on epithelial cell CCSP mRNA expression and CCSP protein synthesis. A human bronchial epithelial cell line (BEAS-2B) was used for this study. CCSP mRNA was detected by ribonuclease protection assay. IFN-gamma was found to increase CCSP mRNA expression in a time- and dose-dependent manner. The CCSP mRNA level increased after IFN-gamma (300 U/ml) treatment for 8-36 h, with the peak increase at 18 h. Immunobloting of CCSP protein also demonstrated that IFN-gamma induced the synthesis and secretion of CCSP protein in a time-dependent manner. Nuclear run-on, CCSP reporter gene activity assay, and CCSP mRNA half-life assay demonstrated that IFN-gamma-induced increases in CCSP gene expression were mediated, at least in part, at the posttranscriptional level. The present study demonstrates that IFN-gamma can induce increases in steady-state mRNA levels and protein synthesis of human CCSP protein in airway epithelial cells and may modulate airway inflammatory responses in this manner.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9612303     DOI: 10.1152/ajplung.1998.274.5.L864

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Association of an intragenic microsatellite marker in the CC16 gene with asthma in the Indian population.

Authors:  Shilpy Sharma; Balaram Ghosh
Journal:  J Hum Genet       Date:  2004-11-12       Impact factor: 3.172

Review 2.  Club Cell Protein 16 (CC16) Augmentation: A Potential Disease-modifying Approach for Chronic Obstructive Pulmonary Disease (COPD).

Authors:  Maria E Laucho-Contreras; Francesca Polverino; Yohannes Tesfaigzi; Aprile Pilon; Bartolome R Celli; Caroline A Owen
Journal:  Expert Opin Ther Targets       Date:  2016-02-11       Impact factor: 6.902

3.  Induction of uteroglobin-related protein 2 (Ugrp2) gene expression by the Th2 cytokines IL-4 and IL-13.

Authors:  Atsushi Yamada; Faruk Sheikh; Tomoaki Niimi; Francesco J DeMayo; Achsah D Keegan; Raymond P Donnelly; Shioko Kimura
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

4.  Regulation of uteroglobin/Clara cell protein expression after acute lung exposure to an organophosphoreted insecticide.

Authors:  Jorge Elia; Agustín Aoki; Cristina A Maldonado
Journal:  Histochem Cell Biol       Date:  2003-07-01       Impact factor: 4.304

5.  Polydatin up-regulates Clara cell secretory protein to suppress phospholipase A2 of lung induced by LPS in vivo and in vitro.

Authors:  Shu Shiyu; Ling Zhiyu; Ye Mao; Bo Lin; Wang Lijia; Zhang Tianbao; Chen Jie; Li Tingyu
Journal:  BMC Cell Biol       Date:  2011-07-25       Impact factor: 4.241

6.  Chronic Pseudomonas aeruginosa infection-induced chronic bronchitis and emphysematous changes in CCSP-deficient mice.

Authors:  Takemasa Matsumoto; Masaki Fujita; Ryosuke Hirano; Junji Uchino; Yukari Tajiri; Satoru Fukuyama; Yasuo Morimoto; Kentaro Watanabe
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-09-20

Review 7.  Distinct spatial and temporal roles for Th1, Th2, and Th17 cells in asthma.

Authors:  Weihang Luo; Jindong Hu; Weifang Xu; Jingcheng Dong
Journal:  Front Immunol       Date:  2022-08-12       Impact factor: 8.786

8.  CC16 levels correlate with cigarette smoke exposure in bronchial epithelial cells and with lung function decline in smokers.

Authors:  David Chi-Leung Lam; Hoi-Hin Kwok; Wai-Cho Yu; Fanny Wai-San Ko; Cheuk-Yin Tam; Arthur Chun-Wing Lau; Daniel Yee-Tak Fong; Mary Sau-Man Ip
Journal:  BMC Pulm Med       Date:  2018-03-16       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.